1. Home
  2. CSTM vs ARQT Comparison

CSTM vs ARQT Comparison

Compare CSTM & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$34.55

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$21.91

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTM
ARQT
Founded
2010
2016
Country
France
United States
Employees
11500
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
CSTM
ARQT
Price
$34.55
$21.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$30.75
$34.00
AVG Volume (30 Days)
2.1M
1.4M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
405.26
88.79
EPS
1.42
N/A
Revenue
$8,449,000,000.00
$376,072,000.00
Revenue This Year
$21.46
$34.85
Revenue Next Year
$0.50
$29.39
P/E Ratio
$23.51
N/A
Revenue Growth
15.19
91.34
52 Week Low
$11.60
$12.72
52 Week High
$34.35
$31.77

Technical Indicators

Market Signals
Indicator
CSTM
ARQT
Relative Strength Index (RSI) 66.42 44.16
Support Level $14.04 $19.60
Resistance Level N/A $24.56
Average True Range (ATR) 1.33 1.24
MACD 0.08 -0.21
Stochastic Oscillator 98.71 45.51

Price Performance

Historical Comparison
CSTM
ARQT

About CSTM Constellium SE (France)

Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: